There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Nyxoah's disrupting Genio implant is likely to revolutionize Obstructive Sleep Apnea, and FDA's decision is expected in Q1 ...

Sleep apnoea is common among older adults but is often overlooked or ignored leading to delayed diagnosis and treatment ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first ...

U.S. regulators have approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

"Today's approval marks the first drug treatment option for certain patients with obstructive sleep apnea," Dr. Sally Seymour, director of the Division of Pulmonology, Allergy, and Critical Care ...

Sometimes other sleep apnea treatments, including surgery, are considered as a treatment for OSA ... study would be useful in diagnosing your condition and exploring treatment options. Resolving sleep ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the disorder affecting millions of Americans. On Friday, the federal agency ...